Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay(125 visite) Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic), 1996 May 1; 236(2): 338-343.
Tipo di articolo: Journal Article,
Impact factor: 2.017, Impact factor a 5 anni: 3.039
Nuclear Medicine Research Laboratory, Mem. Sloan Kettering Cancer Center, New York, NY 10021, United States Lab. of Cell. and Biochem. Genetics, Mem. Sloan Kettering Cancer Center, New York, NY 10021, United States Fordham University, Bronx, NY 10458, United States Inst. of Molec. and Cell. Biosci., University of Tokyo, Tokyo, Japan
Marquardt, D., (1963) Appl. Math., 11, pp. 431-441
Mehta, B.M., Levchenko, A., Patel, D.A., Tsuruo, T., Larson, S.M., (1995) Proc. Am. Assoc. Cancer Res., 36, p. 333
Georges, E., Bradley, G., Gariepy, J., Ling, V., (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 150-156
Munson, P.J., (1983) J. Receptor Res., 3, pp. 249-259
Del Vecchio, S., Reynolds, J.C., Carrasquillo, J.A., Blasberg, R.G., Neumann, R.D., Lotze, M.T., Bryant, G.J., Larson, S.M., (1989) Cancer Res., 49, pp. 2783-2789
Hulme, E. C., (1992) Receptor-Ligand Interactions: a Practical Approach, , IRL Press, Oxfor
Riordan, J. R., Ling, V., (1985) Pharmacol. Ther., 28, pp. 51-75
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., Pastan, I., (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 265-269
Higgins, C. F., (1992) Annu. Rev. Cell. Biol., 8, pp. 67-113
Biedler, J. L., Casals, D., Chang, T. -D., Meyers, M. B., Spengler, B. A., Ross, R. A., (1991) Adv. Neuroblast. Res., 3, pp. 181-191
Fraker, P. J., Speck, J. C., (1978) Biochem. Biophys. Res. Commun., 80, pp. 849-854
Laemmli, U. K., (1970) Nature, 227, p. 680
Badger, C. C., Krohn, K. A., Bernstein, I. D., (1987) Nucl. Med. Biol., 14 (6), pp. 605-610
Mehta, B. M., Levchenko, A., Patel, D. A., Tsuruo, T., Larson, S. M., (1995) Proc. Am. Assoc. Cancer Res., 36, p. 333
Munson, P. J., (1983) J. Receptor Res., 3, pp. 249-259
To date, all reported measurements of multidrug resistance have been semiquantitative. The purpose of the present study is to establish and validate the self-competitive binding assay technique utilizing monoclonal antibody for quantitative estimation of multidrug resistance in tumor cells. This technique is used for P-glycoprotein concentration measurement in BE(2)- C human neuroblastoma cell line and its sublines with primary resistance to colchicine and actinomycin D. Monoclonal antibody MRK-16 was used in this study. It was labeled with iodine-125 (125I) to trace the concentration of antibody-antigen complexes. The binding data were obtained by varying the concentration of the unlabeled antibody. The results were fitted to a model equation to estimate the number of binding sites and antibody-antigen dissociation constant. The P-glycoprotein concentration was significantly higher in the resistant sublines than in the sensitive line. The highest levels were achieved in actinomycin D-resistant cells: 2.1 x 106 binding sites/cell versus 5.4 x 104 binding sites/cell in the sensitive cells. The consistency of the results was verified by repeating the study three times for each cell line. The binding assay results were confirmed by Western blot experiments performed on the same cell lines.
111 Records (103 escludendo Abstract e Conferenze). Impact factor totale: 428.203 (398.999 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 470.685 (435.074 escludendo Abstract e Conferenze).